INHIBITED EXPRESSION OF INSULIN-LIKE-GROWTH-FACTOR-I MESSENGER-RNA AND ATTENUATED CARDIAC-HYPERTROPHY IN VOLUME-OVERLOADED HEARTS TREATED WITH DIFLUOROMETHYLORNITHINE

Citation
P. Friberg et al., INHIBITED EXPRESSION OF INSULIN-LIKE-GROWTH-FACTOR-I MESSENGER-RNA AND ATTENUATED CARDIAC-HYPERTROPHY IN VOLUME-OVERLOADED HEARTS TREATED WITH DIFLUOROMETHYLORNITHINE, Growth hormone & IGF research, 8(2), 1998, pp. 159-165
Citations number
32
Categorie Soggetti
Endocrynology & Metabolism",Biology,"Cell Biology
ISSN journal
10966374
Volume
8
Issue
2
Year of publication
1998
Pages
159 - 165
Database
ISI
SICI code
1096-6374(1998)8:2<159:IEOIMA>2.0.ZU;2-L
Abstract
The present study examined whether the previously reported hypertrophy and increased expression of insulin-like growth factor I (IGF-I) mRNA in the volume-overloaded right ventricle was dependent on an intact p roduction of polyamines. Volume overload was created in normotensive W istar rats by means of an aorto-caval fistula. Difluoromethylornithine (DFMO) 2%, which is a specific, irreversible blocker of ornithine dec arboxylase, was administered in the drinking water to intervention gro ups and one sham group, respectively, 24 h prior to surgery and for up to 26 days. DFMO blocked transiently the early over-expression of rig ht ventricular IGF-I mRNA and attenuated the rapid development of both right and left ventricular hypertrophy during volume overload. Expres sion of IGF-I mRNA in the right ventricle in the early phase of volume overload appears to be dependent on activation of ornithine decarboxy lase, whereas other pathways are involved in the later phase of cardia c structural adaptation. Thus, these findings link together early and late growth responses potentially important for compensatory cardiac h ypertrophy. (C) 1998 Churchill Livingstone